Comparing Idelalisib vs Rituximab
| Idelalisib Remove Idelalisib from your drug comparison | Rituximab Remove Rituximab from your drug comparison |
|---|
| Idelalisib Remove Idelalisib from your drug comparison | Rituximab Remove Rituximab from your drug comparison | |
|---|---|---|
|
Prescribed for Chronic Lymphocytic Leukemia, Follicular Lymphoma, Non-Hodgkin's Lymphoma, Lymphoma. idelalisib may also be used for purposes not listed in this medication guide. |
Prescribed for Diffuse Large B-Cell Lymphoma, Granulomatosis with Polyangiitis, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, Microscopic polyangiitis, Pemphigus... View more |
|
|
Prescription only |
Prescription only |
|
Ratings & Reviews |
||
Drug Class |
||
Side Effects |
||
|
Commonly reported side effects include: hepatotoxicity, pneumonitis, severe colitis, severe diarrhea, exfoliative dermatitis, pneumonia, colitis, abdominal pain, cough, dyspnea, erythematous rash, fever, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, macular eruption, maculopapular rash, nausea, neutropenia, pruritic rash, skin rash, and vomiting. See the full idelalisib side effects document. |
See the full rituximab side effects document. |
|
Pricing and Coupons* Prices are without insurance |
||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Generic Availability |
||
|
No |
No |
|
Dosage Form(s) Available |
||
| N/A | N/A | |
Brand Names |
||
| Zydelig | Riabni, Rituxan, Ruxience, Truxima | |
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||
|
8.2 hours |
59.8 hours |
|
CSA Schedule**View glossary of terms. |
||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category |
||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
|
FDA Alerts |
||
|
N/A |
||
Drug Interactions |
||
|
A total of 740 drugs are known to interact with idelalisib:
|
A total of 129 drugs are known to interact with rituximab:
|
|
Alcohol/Food/Lifestyle Interactions |
||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions |
||
First Approval Date |
||
|
July 23, 2014 |
November 26, 1997 |
|
WADA ClassView World Anti-Doping Agency classifications. |
||
|
N/A |
N/A |
|
More Information |
||
Consumer Resources |
||
Professional Resources |
||
Related Treatment Guide |
||
|
||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.